Mithra Pharmaceuticals SA - Company Profile

Powered by

All the data and insights you need on Mithra Pharmaceuticals SA in one report.

$195 $295
Buy Report View Sample
  • Save hours of research time and resources with
    our up-to-date Mithra Pharmaceuticals SA Strategy Report

  • Understand Mithra Pharmaceuticals SA position in the market,
    performance and strategic initiatives.

  • Gain competitive edge and increase your
    chances of success

Back to companies

Mithra Pharmaceuticals SA: Overview

Select Item

Related keylists

Mithra Pharmaceuticals SA (Mithra) is a biotech company that develops and manufactures over the counter products for women’s health and other applications. The company offers various drug products including Donesta, Estelle, tibelia, myring and zoreline. Mithra offers its products in polymeric forms, hormonal tablets, and sterile injectable products. The company also provides CDMO services such as drug development and supporting services. It offers its products under various brands including Tibelia, Estelle and Donesta. Its products are used in the treatment of contraception and fertility, gynecological infections, menopause and osteoporosis and cancers. The company offers its products through a network of distributors in Belgium, France, Germany, Luxemburg and Brazil. Mithra is headquartered in Liege, Belgium.

 Gain a 360-degree view of Mithra Pharmaceuticals SA and make more informed decisions for your business Gain a 360-degree view of Mithra Pharmaceuticals SA and make more informed decisions for your business Find out more
Headquarters Belgium
Address Rue Saint-Georges 5, Liege, 4000
Website www.mithra.com
Telephone 32 4 3492822
No of Employees 229
Industry Pharmaceuticals and Healthcare
Ticker Symbol & Exchange MITRA (EBR)
Revenue (2022) $43.4M -40.1% (2022 vs 2021)
EPS XYZ
Net Income (2022) XYZ -191% (2022 vs 2021)
Market Cap* $16.1M
Net Profit Margin (2022) XYZ -385.5% (2022 vs 2021)
* As of and is in US$
View Mithra Pharmaceuticals SA financials
Gain access to our premium signals and make informed decisions for your business Gain access to our premium signals and make informed decisions for your business Find out more

Mithra Pharmaceuticals SA premium industry data and analytics

70+

Lead Sheet

Understand when and why to target accounts of prospective leads, as well as who to reach out to, drawing on intelligence for Mithra Pharmaceuticals SA’s relevant decision makers and contact details.

50+

Clinical Trials

Determine Mithra Pharmaceuticals SA go-to-market proposition and gain insight into the company’s clinical operations, recruitment, and trial strategy.

40+

Catalyst Calendar

Proactively evaluate Mithra Pharmaceuticals SA’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.

16+

Marketed Drugs

Understand Mithra Pharmaceuticals SA’s commercialized product portfolio to stay one step ahead of the market.

7

Pipeline Drugs

Identify which of Mithra Pharmaceuticals SA’s products will be commercialized, helping you to better contend with shifting product portfolios, and allowing you to stay one step ahead of the market.

2

Regulatory Milestones

Track drug and patent expiries along with geographies impacted.

1

Insights

Remove risk and uncertainty, gain a competitive edge and secure actionable leads with access to company-related investigative journalist content.

Products and Services

Products Services Brands
Estetrol: Drug Development Myring
Estelle - Contraception Pharmaceutical Development Zoreline
Donesta - Menopause Stability Studies Tibelia
XYZ XYZ XYZ
XYZ XYZ XYZ
XYZ XYZ XYZ
Understand Mithra Pharmaceuticals SA portfolio and identify potential areas for collaboration Understand Mithra Pharmaceuticals SA portfolio and identify potential areas for collaboration Find out more

History

History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.

Year Event Description
2023 Contracts/Agreements In December, the company announced the signing of a binding Head of Terms with Gedeon Richter for the development and commercialization of ESTELLE and DONESTA in China.
2023 Others In November, the company granted an additional patent for NEXTSTELLIS in the US.
2023 Contracts/Agreements In August, the company and Gedeon Richter Plc signed a binding supply agreement for the active pharmaceutical ingredient (API) for the combined oral contraceptive Estelle and Donesta.
Dive into past operations, including product releases, deals, acquisitions & more Dive into past operations, including product releases, deals, acquisitions & more Find out more
Image for loader

Competitor Comparison

Key Parameters Mithra Pharmaceuticals SA Galapagos NV TherapeuticsMD Inc Celyad Oncology SA Endoceutics Inc
Headquarters Belgium Belgium United States of America Belgium Canada
City Liege Malines (Mechelen) Boca Raton Mont-Saint-Guibert Quebec City
State/Province Liege - Florida - Quebec
No. of Employees 229 646 1 12 1,200
Entity Type Public Public Public Public Private
Benchmark the company against the market with exclusive information on key competitors Benchmark the company against the market with exclusive information on key competitors Find out more
Chart Financial activity with access to more key stats Chart Financial activity with access to more key stats Find out more
Executives
Name Position Board Since Age
Christian Homsy Chairman Executive Board 2023 75
Erik Van Den Eynden Vice Chairman Executive Board 2022 -
Jean-Michel Foidart Director Executive Board 2021 73
Christophe Marechal Co-Chief Executive Officer; Chief Financial Officer Senior Management 2024 -
Cedric Darcis General Counsel; Chief Legal Officer Senior Management - -
Non Dignissim Eros Proin vel Convallis 2024 XY
Non Dignissim Eros Proin vel Convallis 2024 XY
Non Dignissim Eros Proin vel Convallis 2024 XY
Gain insight into Mithra Pharmaceuticals SA key executives to enhance your sales strategy Gain insight into Mithra Pharmaceuticals SA key executives to enhance your sales strategy Find out more
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward